Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michel Detheux currently holds 57,162 shares of iTeos Therapeutics, Inc. (ITOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michel Detheux has been a net seller of ITOS stock. They have purchased $0 and sold $7.4M worth of shares.
Michel Detheux's most recent insider trade was on Jun 11, 2026, when they sold 57,162 shares at $0.00 per share.
Michel Detheux serves as Executive at iTeos Therapeutics, Inc. (ITOS). They have executed 50 insider transactions totaling $7.4M over their tenure at the company.
Michel Detheux holds the position of Executive at iTeos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Michel Detheux has shown a selling trading pattern, with $0 in total purchases and $7.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michel Detheux was on Jun 14, 2021, when they sold $711.3K worth of ITOS shares. This transaction involved 25,063 shares at $28.38 per share.
Michel Detheux currently owns 57,162 shares of iTeos Therapeutics, Inc. (ITOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michel Detheux's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michel Detheux has 50 Form 4 filings on record as an insider at iTeos Therapeutics, Inc..
Set alerts for Michel Detheux and 40,000+ other insiders.